Current Trial Listing

Condition	Trial Name	Sponsor
Non-Small Cell Lung Cancer	AndroMETa-Lung-536: Telisotuzumab Adizutecan in Combination With IV Budigalimab in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC	AbbVie
Non-Small Cell Lung Cancer	ARTEMIA: Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor	OSE Immunotherapeutics
Breast Cancer	ASCENT-05: Adjuvant Sacituzumab Govitecan Plus Pembrolizumab for Patients with Triple Negative Breast Cancer	Gilead Sciences, Inc.
Breast Cancer	BRIA-ABC: Bria-IMT plus Immunotherapy for Patients with Pre-Treated Metastatic Breast Cancer	BriaCell Therapeutics Corporation
Non-Small Cell Lung Cancer	COPERNICUS: A Phase 2b, Open-Label, Study of Subcutaneous Amivantamab in Combination With Lazertinib as First-Line Treatment	Janssen Research & Development, LLC
Small Cell Lung Cancer	DeLLphi-312: A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer	Amgen
Breast Cancer	First-in-Human, Escalating Oral Dose Study of RGT-419B Given Alone and with Endocrine Therapy in Subjects with Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced/Metastatic Breast Cancer	Regor Pharmaceuticals Inc.
Chemotherapy Induced Peripheral Neuropathy	IMPACT: Lilac Boot and Glove Device for the Prevention of Chemotherapy Induced Peripheral Neuropathy	Luminate Medical, Inc.
Colorectal Cancer	INCA033890-303: A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer	Incyte Corporation
Colorectal Cancer	INTRINSIC: A Multi-Arm Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer	Hoffmann-La Roche
Breast Cancer	MoonROSE: CDK2/4/6 Inhibitor GDC-4198 in Combination with Giredestrant for Patients with ER+, HER2- Metastatic Breast Cancer After Treatment with a CDK4/6 Inhibitor	Genentech, Inc.
Colorectal Cancer	OrigAMI-2: Amivantamab + Chemotherapy Versus Cetuximab + Chemotherapy in Treatment-naïve Participants with KRAS/NRAS and BRAF Wild-type Colorectal Cancer	Janssen Research & Development, LLC
Colorectal Cancer	OrigAMI-3: Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With Recurrent KRAS/NRAS and BRAF Wild-type Colorectal Cancer	Janssen Research & Development, LLC
Advanced Solid tumors	Phase 1 Study of SGN-B6A in Advanced Solid Tumors	Seagen Inc.
Chronic Myeloid Leukemia	POLARIS-2: Study of Olverembatinib (HQP1351) in Patients With CP-CML	Ascentage Pharma Group Inc.
Solid Tumors or Multiple Myeloma	QXL138AM-001: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma	Nammi Therapeutics Inc
Cancer Diagnosis	[Registry] MSK-IMPACT/ACCESS Genomic Profiling in Cancer Patients	Memorial Sloan Kettering Cancer Center
Breast Cancer	ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer	BioNTech SE
Various Indications	[Sample Collection] Clinical Biospecimen Procurement Protocol to Support Advancements in Medical Diagnoses of Diseases (PROMEDx)	Precision for Medicine
Solid Tumors	[Sample Collection] Collection and Distribution of Biofluids for Research Purposes	Bluestar Genomics
Solid Tumors	[Sample Collection] Detecting cancers Earlier Through Elective plasma-based Cancer SEEK Testing (DETECT-ASCEND 2)	Exact Sciences Thrive LLC
Various Indications	[Sample Collection] Prospective Collection of Samples for Research (SERATRIALS-05035)	SERATRIALS, LLC.
Solid Tumors	[Sample Collection] Vallania: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening	Freenome Holdings Inc.
Chemotherapy Induced Thrombocytopenia	SHR8735-303: A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia	Jiangsu HengRui Medicine Co., Ltd.
Breast Cancer	SIGNAL-ER 101: Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer	Natera, Inc.
Pancreatic Cancer	TRIDENT: Relacorilant in Combination with Chemotherapy for the First Line Treatment of Pancreatic Cancer	Corcept Therapeutics
Multiple Myeloma	TRIlogy-5: A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma	Janssen Research & Development, LLC

Need More Information?

Our team is here to help answer your questions and guide you through your options.

Call (855) 528-7322 Request Appointment